U.S. Depyrogenated Sterile Empty Vials Market Size, Share & Trends Analysis Report By Product (2 ml, 5 ml, 10 ml, 20 ml), By End-use (Clinical Labs, Compounding Labs), And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. End-use
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. End-use outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Depyrogenated Sterile Empty Vials Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
  • 3.3.2. Market restraint analysis
• 3.4. U.S. Depyrogenated Sterile Empty Vials Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape

Chapter 4. U.S. Depyrogenated Sterile Empty Vials Market: Product Estimates & Trend Analysis

• 4.1. U.S. Depyrogenated Sterile Empty Vials Market: Key Takeaways
• 4.2. U.S. Depyrogenated Sterile Empty Vials Market: Movement & Market Share Analysis, 2022 & 2030
• 4.3. 2 ml
  • 4.3.1. 2 ml market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.4. 5 ml
  • 4.4.1. 5 ml market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. 10 ml
  • 4.5.1. 10 ml market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.6. 20 ml
  • 4.6.1. 20 ml market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.7. More than 20 ml
  • 4.7.1. More than 20 ml market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. U.S. Depyrogenated Sterile Empty Vials Market: End-use Estimates & Trend Analysis

• 5.1. U.S. Depyrogenated Sterile Empty Vials Market: Key Takeaways
• 5.2. U.S. Depyrogenated Sterile Empty Vials Market: Movement & Market Share Analysis, 2022 & 2030
• 5.3. Clinical Labs
  • 5.3.1. Clinical labs market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.4. Compounding Labs
  • 5.4.1. Compounding labs market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.5. Others
  • 5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company Market Categorization
  • 6.2.1. Thermo Fisher Scientific, Inc.
    • 6.2.1.1. Company overview
    • 6.2.1.2. Financial performance
    • 6.2.1.3. Product benchmarking
    • 6.2.1.4. Strategic initiatives
  • 6.2.2. VWR International, LLC
    • 6.2.2.1. Company overview
    • 6.2.2.2. Financial performance
    • 6.2.2.3. Product benchmarking
    • 6.2.2.4. Strategic initiatives
  • 6.2.3. Stevenato Group
    • 6.2.3.1. Company overview
    • 6.2.3.2. Financial performance
    • 6.2.3.3. Product benchmarking
    • 6.2.3.4. Strategic initiatives
  • 6.2.4. SiO2 Medical Products, Inc.
    • 6.2.4.1. Company overview
    • 6.2.4.2. Financial performance
    • 6.2.4.3. Product benchmarking
    • 6.2.4.4. Strategic initiatives
  • 6.2.5. DWK Life Sciences
    • 6.2.5.1. Company overview
    • 6.2.5.2. Financial performance
    • 6.2.5.3. Product benchmarking
    • 6.2.5.4. Strategic initiatives
  • 6.2.6. Merck KGaA
    • 6.2.6.1. Company overview
    • 6.2.6.2. Financial performance
    • 6.2.6.3. Product benchmarking
    • 6.2.6.4. Strategic initiatives
  • 6.2.7. Corning, Inc.
    • 6.2.7.1. Company overview
    • 6.2.7.2. Financial performance
    • 6.2.7.3. Product benchmarking
    • 6.2.7.4. Strategic initiatives
  • 6.2.8. SCHOTT Corporation
    • 6.2.8.1. Company overview
    • 6.2.8.2. Financial performance
    • 6.2.8.3. Product benchmarking
    • 6.2.8.4. Strategic initiatives

List of Tables

• Table 1 List of Abbreviations
• Table 2 U.S. U.S. depyrogenated sterile empty vials market, by product, 2018 - 2030 (USD Million)
• Table 3 U.S. U.S. depyrogenated sterile empty vials market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 U.S. depyrogenated sterile empty vials: Market outlook
• Fig. 9 U.S. depyrogenated sterile empty vials competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 Industry value chain analysis
• Fig. 14 U.S. depyrogenated sterile empty vials market driver impact
• Fig. 15 U.S. depyrogenated sterile empty vials market restraint impact
• Fig. 16 U.S. depyrogenated sterile empty vials market strategic initiatives analysis
• Fig. 17 U.S. depyrogenated sterile empty vials market: Product movement analysis
• Fig. 18 U.S. depyrogenated sterile empty vials market: Product outlook and key takeaways
• Fig. 19 2 ml market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 5 ml market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 10 ml market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 20 ml market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 More than 20 ml market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 U.S. depyrogenated sterile empty vials market: End-use movement analysis
• Fig. 25 U.S. depyrogenated sterile empty vials market: End-use outlook and key takeaways
• Fig. 26 Clinical labs market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Compounding labs market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Others market estimates and forecasts, 2018 - 2030 (USD Million)